Details:

Personal Author:
Bell, Beth P. ; Wasley, Annemarie ; Shapiro, Craig N. ; Margolis, Harold S.
Bell, Beth P. ; Wasley, Annemarie ; Shapiro, Craig N. ; Margolis, Harold S. Less -
Corporate Authors:
Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.). Division of Viral and Rckettsial Diseases.
Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.). Division of Viral and Rckettsial Diseases. Less -
Description:
Routine vaccination of children is the most effective way to reduce hepatitis A incidence nationwide over time. Since licensure of hepatitis A vaccine in 1995, this strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest rates of infection and disease. These updated recommendations represent the next phase of this hepatitis A immunization strategy. Vaccination of children living in states and communities with consistently elevated rates of hepatitis A will provide protection from disease and is expected to reduce the overall incidence of hepatitis A. This report updates the ACIP's 1996 recommendations on the prevention of hepatitis A through immunization (MMWR 1996;45:[No. RR-151) and includes a) new data about the epidemiology of hepatitis A; b) recent findings about the effectiveness of community-based hepatitis A vaccination programs; and c) recommendations for the routine vaccination of children in states, counties, and communities with rates that are twice the 1987-1997 national average or greater (i.e., > or = 20 cases per 100,000 population) and consideration of routine vaccination of children in states, counties, and communities with rates exceeding the 1987-1997 national average (i.e., > or = 10 but <20 cases per 100,000 population). Unchanged in this report are previous recommendations regarding the vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A.
Content Notes:
The following CDC staff members prepared this report: Beth P. Bell, Annemarie Wasley, Craig N. Shapiro, Harold S. Margolis, Division of Viral and Rckettsial Diseases, National Center for Infectious Diseases.

Includes bibliographical references (p. 31-37).

Man-HueiChang/Dholtzman

2/21/2014


Subjects:
[+]
Hepatitis A/prevention & Control Hepatitis A Vaccines/administration & Dosage Immunization, Passive Vaccination
Source:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1999; 48(RR-12):1-37.
Series:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 48, no. RR-12
Pubmed ID:
10543657
Document Type:
Journal Issue
Genre:
Practice Guideline
Place as Subject:
United States
Collection(s):
Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:c2b835d9510c8a07ab1844a65c414283c3c086da3c75c58841e49ce421a5dfef
Download URL:
https://stacks.cdc.gov/view/cdc/6719/cdc_6719_DS1.pdf
File Type:

Supporting Files

• No Additional Files

More +